Literature DB >> 9663592

Germline mutations in the vhl gene in patients presenting with phaeochromocytomas.

E van der Harst1, R R de Krijger, W N Dinjens, L E Weeks, H J Bonjer, H A Bruining, S W Lamberts, J W Koper.   

Abstract

It has been shown that an appreciable percentage of patients presenting with primary, apparently sporadic phaeochromocytomas may in fact have von-Hippel-Lindau (VHL) disease. In order to investigate this, we retrospectively screened 68 patients, who had been operated on for phaeochromocytomas, for the presence of germline mutations in the vhl gene. DNA was isolated from peripheral-blood leukocytes and used to screen the entire coding sequence and the intron-exon boundaries of the vhl gene for mutations, using a PCR-based SSCP strategy. When an abnormal pattern was found in the SSCP analysis, sequence analysis was carried out. We found SSC variants in the vhl gene in 8 of the 68 patients. Of 6 patients, 2 turned out to be related (an uncle and his nephew), and they carried the same mis-sense mutation: R64P. In 4 other patients, mis-sense mutations, P25L, L63P, G144Q and I147T, were also identified. None of these mutations has been described, and 3 of them (P25L, L63P and R64P) are located closer to the N terminus of the vhl protein than any reported vhl mutation. In the remaining 2 cases, the mutations were localized not in the coding sequence but in the intronic sequence (but not within splice-sites), adjacent to the exon, so they were probably not related to the disease. Our results show that a relatively high proportion (6/68, or 8.8%), though not as high as the 20% reported earlier, of patients with apparently sporadic phaeochromocytomas may carry germline mutations in the vhl gene.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9663592     DOI: 10.1002/(sici)1097-0215(19980729)77:3<337::aid-ijc5>3.0.co;2-p

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Losses of chromosomes 1p and 3q are early genetic events in the development of sporadic pheochromocytomas.

Authors:  H Dannenberg; E J Speel; J Zhao; P Saremaslani; E van Der Harst; J Roth; P U Heitz; H J Bonjer; W N Dinjens; W J Mooi; P Komminoth; R R de Krijger
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  Computational detection of deleterious SNPs and their effect on sequence and structural level of the VHL gene.

Authors:  R Rajasekaran; C Sudandiradoss; C George Priya Doss; Anshuman Singh; Rao Sethumadhavan
Journal:  Mamm Genome       Date:  2008-10-03       Impact factor: 2.957

3.  VHL P25L is not a pathogenic von Hippel-Lindau mutation: a family study.

Authors:  Rachel K Pettman; Amy Crowley; Christie Riddell; Mark D Ludman
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

Review 4.  Hereditary paraganglioma targets diverse paraganglia.

Authors:  B E Baysal
Journal:  J Med Genet       Date:  2002-09       Impact factor: 6.318

5.  Von hippel-lindau disease.

Authors:  Frederik J Hes; Jo Wm Höppener; Rob B van der Luijt; Cornelis Jm Lips
Journal:  Hered Cancer Clin Pract       Date:  2005-11-15       Impact factor: 2.857

6.  Proteostasis modulators prolong missense VHL protein activity and halt tumor progression.

Authors:  Chunzhang Yang; Kristin Huntoon; Alexander Ksendzovsky; Zhengping Zhuang; Russell R Lonser
Journal:  Cell Rep       Date:  2013-01-10       Impact factor: 9.423

Review 7.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

8.  A c.464T>a mutation in VHL gene in a Chinese family with VHL syndrome.

Authors:  Yan Lu; Jun Lu; Qiang Liu; Jian Niu; Shi-Ming Zhang; Qing-Yu Wu; Xiao-Fei Qi
Journal:  J Neurooncol       Date:  2012-12-01       Impact factor: 4.130

9.  Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations.

Authors:  Carme Camps; Nayia Petousi; Celeste Bento; Holger Cario; Richard R Copley; Mary Frances McMullin; Richard van Wijk; Peter J Ratcliffe; Peter A Robbins; Jenny C Taylor
Journal:  Haematologica       Date:  2016-09-20       Impact factor: 9.941

10.  Ubiquitin/SUMO modification regulates VHL protein stability and nucleocytoplasmic localization.

Authors:  Qiliang Cai; Erle S Robertson
Journal:  PLoS One       Date:  2010-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.